March Bulletin
Issue 54
Community Notices | News | Jobs | Funding | Events
Community Notices
The Marble Center has a new website!
We hope you’d notice! Let us know what you think.
March seminar
This month's Marble Center seminar is on Monday March 22nd (11am-noon, via Zoom) with a research update by Erin B. Rousseau of the Langer Lab. The title of her talk is “A platform for micro-invasive membrane free sampling of interstitial space.” Following the research update, we will host an update from Dr. Abigail Lytton-Jean on the Peterson (1957) Nanotechnology Materials Core Facility.
A platform for micro-invasive membrane free sampling of interstitial space
Erin B. Rousseau (Langer Lab)
Missed the last hot topic discussion?
Last month, Dr. Padmini Pillai of the Langer Lab led a hot topic discussion on allergic reactions behind COVID-19 mRNA vaccines. You can now view the recording on our hot topic page.
Save the date!
Professor Joe DeSimone, Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University, will be speaking at the upcoming Marble Center Distinguished Seminar Monday April 26, 2021 (11am-noon). Access the event page here.
In the News
Future Founders Initiative
MIT faculty, including Marble Center Director Prof. Sangeeta Bhatia, collaborate with members of the Boston-area biotech community to commercialize women’s discoveries and promote female entrepreneurship.
STAT Madness!
STAT Madness has begun. Check out this awesome new technology developed at the Koch Institute labs (also feature presentation at this month’s Marble Center seminar!) and vote for the best innovations in biomedicine.
THRILLED to be in #STATmadness! We have developed a tool for micro-invasive liquid biopsies of the brain that enables discovering & tracking biomarkers of disease that cannot be captured using other methods. Please vote for us in Matchup 27! https://t.co/Ndm5Yg6AS8@kochinstitute
— Ritu Raman (@DrRituRaman) March 1, 2021
Break Through Cancer
The Koch Institute for Integrative Cancer Research at MIT is partnering with Break Through Cancer on a collaborative approach to research and cures for the most complex and challenging cancers.
You can check out the website or read this article in The Cancer Letter.
Jobs
Senior/Scientist Pulmonary Immunobiology.
Translate Bio is seeking an experienced Scientist or Sr. Scientist to join our growing Target Biology team. The individual in this role will contribute to drug discovery efforts at Translate Bio, particularly focused on lung diseases with high unmet need. He/She will conduct hands-on research to identify and validate new target opportunities, contribute to our understanding of lung drug delivery and efficacy, and help develop and implement new analytical and therapeutic technologies. Read More…
Sr./Scientist, Analytical Development, Moderna Therapeutics.
The role is a multidisciplinary position that involves investigating lipid nanoparticle and mRNA manufacturing technologies with established and novel analytical techniques. This scientific leadership role will be responsible for investigating physico-chemical characterization methods of mRNA formulations in a dynamic and highly interdisciplinary environment. He/she will balance internal effort with external initiatives to identify, organize and engage in collaborations between research, development, and manufacturing organizations. The candidate should have the ability to investigate analytical, manufacturing, and formulation issues and document appropriately in technical reports. In addition, the candidate should be able to contribute characterization source documentation to support regulatory submissions. The ability to identify analytical needs and contribute to characterization through various cross-functional initiatives is a necessary requirement. A breadth of knowledge of analytical tools and techniques applied to materials science, colloidal structure and stability, nanotechnologies for formulation design, nucleic acid drug delivery and general pharmaceutical R&D is required. Read More…
RA/Sr. RA/Assoc. Sci. – Delivery Sciences, Orna Therapeutics.
Orna Therapeutics is a start-up company creating fully engineered circular RNA (oRNA) therapeutics – an entirely new class of RNA medicines that can realize the full potential of RNA. We are seeking exceptional researchers of varying experience levels to join the Delivery Sciences Team to help develop our best-in-class proprietary RNA expression and delivery platform. The ideal candidate will have direct experience with formulating, characterizing, and innovating RNA lipid nanoparticles. In this position, the candidate will design and execute experiments to facilitate preclinical development of lead RNA lipid nanoparticles (including lyophilization, stability, storage, and scale-up studies) and actively collaborate with the Immunology and Molecular Biology teams to support in vitro and in vivo projects. The candidate will also contribute to a positive and exciting work environment in a young, fast-growing company. Contact Kevin Kauffman for more details (kkauffman@ornatx.com). (Additional open positions on other teams at Orna can be found at https://www.ornatx.com/careers/).
Funding opportunities
| Funding Source | Grant ID | Deadline |
|---|---|---|
| NIH/NCI: Toward Translation of Nanotechnology Cancer Interventions | PAR-20-116 | November 18, 2021 |
| The Sontag Foundation: Distinguished Scientist Award | N/A | March 17, 2021 |
